Skip to main content
Clinical Trials/NCT03903731
NCT03903731
Completed
N/A

Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcomes Measures

Smith & Nephew, Inc.5 sites in 3 countries600 target enrollmentJuly 19, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Journey II BCS Total Knee System
Sponsor
Smith & Nephew, Inc.
Enrollment
600
Locations
5
Primary Endpoint
Revision of one or more study device components
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcome Measures.

Registry
clinicaltrials.gov
Start Date
July 19, 2018
End Date
August 8, 2019
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject received primary uni- or bi-lateral total knee arthroplasty with the Journey II BCS Total Knee System for approved indication;
  • The TKA occurred at least 12 weeks prior to enrollment
  • Subject records contain Patient Reported Outcome data obtained ≤3 months prior to as well as ≥6 months post-enrollment.

Exclusion Criteria

  • Subject received the JOURNEY II BCS Total Knee System on the affected knee as a revision for a previously failed total or unicondylar knee arthroplasty

Outcomes

Primary Outcomes

Revision of one or more study device components

Time Frame: Implantation through study completion, approximately 8 years

We are measuring the number of revision cases

Secondary Outcomes

  • Health care utilization: Rehabilitation(Implantation through study completion, approximately 8 years)
  • Knee Injury and Osteoarthritic Outcome Score (KOOS)(Baseline through last study visit, approximately 8 years)
  • Knee Injury and Osteoarthritic Outcome Score Jr (KOOS Jr)(Baseline through last study visit, approximately 8 years)
  • Knee Society Score (KSS)(Baseline through last study visit, approximately 8 years)
  • Return to Work(Implantation through study completion, approximately 8 years)
  • Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index(Baseline through last study visit, approximately 8 years)
  • Oxford Knee Assessment (OKS)(Baseline through last study visit, approximately 8 years)
  • Visual Analogue Scale (VAS)(Baseline through last study visit, approximately 8 years)
  • SF-12 Version 1(Baseline through last study visit, approximately 8 years)
  • Total Knee Assessment Score(Baseline through last study visit, approximately 8 years)

Study Sites (5)

Loading locations...

Similar Trials